Neopterin

interferon alpha 1 ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24088361 Saturable human neopterin response to interferon-α assessed by a pharmacokinetic-pharmacodynamic model. 2013 Oct 2 2
2 22191466 Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. 2012 May 1
3 23272809 Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial. 2012 Dec 28 1
4 21364300 Preparation of branched dextran microspheres of soluble interferon-alpha and its activity in vitro and in vivo. 2011 Feb 2
5 20411806 [Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation]. 2010 Apr 1
6 18457922 Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cells. 2008 Jun 13 2
7 18609142 Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a. 2008 1
8 16144928 Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia. 2005 Sep 1 1
9 16273760 Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. 2005 Jul-Aug 1
10 16339068 Gamma interferon is dispensable for neopterin production in vivo. 2005 Dec 1
11 15153315 Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. 2004 May 2
12 12860366 Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients. 2003 Jul 15 1
13 11804830 Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C. 2002 Jan 1
14 12488496 Monocyte-derived dendritic cells release neopterin. 2002 Dec 1
15 9030876 Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. 1997 Feb 1
16 8878389 Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution. 1996 Oct 15 1
17 8136311 Neopterin release by myeloid leukaemic cells can be synergistically augmented by 1,25-dihydroxyvitamin D3 in combination with gamma interferon or granulocyte-macrophage colony stimulating factor. 1994 Jan 2
18 8471593 Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta. 1993 Apr 1
19 1341444 Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b. 1992 Jul-Aug 1
20 2129033 Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma. 1990 Sep-Oct 1
21 2171163 Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. 1990 Oct 1
22 2725061 Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. 1989 Jun 1
23 2452128 Selective induction of mononuclear phagocytes to produce neopterin by interferons. 1988 Feb 3
24 3068316 Biochemical host response to interferon-beta. 1988 Dec 1
25 3148378 In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). 1988 Dec 1
26 3524022 [Interferon-alpha in the treatment of hematologic neoplasms]. 1986 Apr 30 2
27 6429267 Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. 1984 Jul 1 1